Abstract
PTEN is a tumor suppressor gene that is frequently mutated in human tumors. It functions primarily as a lipid phosphatase and plays a key role in the regulation of phosphatidylinositol-3′-kinase. PTEN appears to play a crucial role in modulating apoptosis by reducing the levels of PtdIns(3,4,5)P3, a phospholipid that activates AKT, a central regulator of apoptosis. To understand the role of PTEN in regulating cell proliferation and apoptosis, we stably overexpressed PTEN in PC3 cells, which are prostate cancer cells that lack PTEN. Overexpression of PTEN in two different clones inhibited cell proliferation and increased serum starvation-induced apoptosis, as compared to control cells. Interestingly, PTEN overexpression resulted in a 44–60% reduction in total insulin-like growth factor-I receptor (IGF-IR) protein levels and a 49–64% reduction in cell surface IGF-IR expression. [35S]methionine pulse experiments in PC3 cells overexpressing PTEN demonstrated that these cells synthesize significantly lower levels of the IGF-IR precursor, whereas PTEN overexpression had no effect on IGF-IR degradation. Taken together, our results show that PTEN can regulate cell proliferation and apoptosis through inhibition of IGF-IR synthesis. These results have important implications for understanding the roles of PTEN and the IGF-IR in prostate cancer cell tumorigenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Beresford SA, Davies MA, Gallick GE and Donato NJ . (2001). J. Interferon. Cytokine. Res., 21, 313–322.
Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S and Reed JC . (1998). Science, 282, 1318–1321.
Chakraborty M, Qiu SG, Vasudevan KM and Rangnekar VM . (2001). Cancer Res., 61, 7255–7263.
Comer FI and Parent CA . (2002). Cell, 109, 541–544.
Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y and Greenberg ME . (1997). Cell, 91, 231–241.
Davies MA, Kim SJ, Parikh NU, Dong Z, Bucana CD and Gallick GE . (2002). Clin. Cancer Res., 8, 1904–1914.
Dong JT, Li CL, Sipe TW and Frierson Jr HF . (2001). Clin. Cancer Res., 7, 304–308.
Dupont J, Khan J, Qu BH, Metzler P, Helman L and LeRoith D . (2001). Endocrinology, 142, 4969–4975.
Dupont J, Renou JP, Shani M, Hennighausen L and LeRoith D . (2002). J. Clin. Invest., 110, 815–825.
Fernandez M and Eng C . (2002). Clin. Cancer Res., 8, 1695–1698.
Freeman DJ, Li AG, Wei G, Li HH, Kertesz N, Lesche R, Whale AD, Martinez-Diaz H, Rozengurt N, Cardiff RD, Liu X and Wu H . (2003). Cancer Cell, 3, 117–130.
Gomez-Manzano C, Fueyo J, Jiang H, Glass TL, Lee HY, Hu M, Liu JL, Jasti SL, Liu TJ, Conrad CA and Yung WK . (2003). Ann. Neurol., 53, 109–117.
Haglund K, Sigismund S, Polo S, Szymkiewicz I, Di Fiore PP and Dikic I . (2003). Nat. Cell Biol., 5, 461–466.
Huang J and Kontos CD . (2002). Arterioscler. Thromb. Vasc. Biol., 22, 745–751.
Jullien J, Guili V, Reichardt LF and Rudkin BB . (2002). J. Biol. Chem., 277, 38700–38708.
Kandel ES, Skeen J, Majewski N, Di Cristofano A, Pandolfi PP, Feliciano CS, Gartel A and Hay N . (2002). Mol. Cell. Biol., 22, 7831–7841.
Koul D, Shen R, Garyali A, Ke LD, Liu TJ and Yung WK . (2002). Int. J. Oncol., 21, 469–475.
LeRoith D, Werner H, Beitner-Johnson D and Roberts Jr CT . (1995). Endocr. Rev., 16, 143–163.
Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH and Parsons R . (1997). Science, 275, 1943–1947.
Ma Q, Renzelli AJ, Baldwin KT and Antonini JM . (2000). J. Biol. Chem., 275, 12676–12683.
Mamillapalli R, Gavrilova N, Mihaylova VT, Tsvetkov LM, Wu H, Zhang H and Sun H . (2001). Curr. Biol., 11, 263–267.
Pene F, Claessens YE, Muller O, Viguie F, Mayeux P, Dreyfus F, Lacombe C and Bouscary D . (2002). Oncogene, 21, 6587–6597.
Reiss K, Porcu P, Sell C, Pietrzkowski Z and Baserga R . (1992). Oncogene, 7, 2243–2248.
Reiss K, Wang JY, Romano G, Furnari FB, Cavenee WK, Morrione A, Tu X and Baserga R . (2000). Oncogene, 19, 2687–2694.
Seely BL, Samimi G and Webster NJ . (2002). BMC Cancer, 2, 1–9.
Sonenberg N and Gingras AC . (1998). Curr. Opin. Cell Biol., 10, 268–275.
Stambolic V . (2002). Trends Pharmacol. Sci., 23, 104–106.
Stiles B, Gilman V, Khanzenzon N, Lesche R, Li A, Qiao R, Liu X and Wu H . (2002). Mol. Cell. Biol., 22, 3842–3851.
Tanno S, Tanno S, Mitsuuchi Y, Altomare DA, Xiao GH and Testa JR . (2001). Cancer Res., 61, 589–593.
Tomic-Carruthers N and Gorden P . (1998). Biochem. Biophys. Res. Commun., 244, 728–731.
Vander Heiden MG and Thompson CB . (1999). Nat. Cell Biol., 1, E209–E216.
Weng LP, Brown JL and Eng C . (2001a). Hum. Mol. Genet., 10, 237–242.
Weng LP, Brown JL and Eng C . (2001b). Hum. Mol. Genet., 10, 599–604.
Weng LP, Brown JL, Baker KM, Ostrowski MC and Eng C . (2002). Hum. Mol. Genet., 11, 1687–1696.
Weng LP, Smith WM, Brown JL and Eng C . (2001c). Hum. Mol. Genet., 10, 605–616.
Wu Y, Yakar S, Zhao L, Hennighausen L and LeRoith D . (2002). Cancer Res., 62, 1030–1035.
Yamada KM and Araki M . (2001). J. Cell. Sci., 114, 2375–2382.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is a ‘United State Government Work’ paper as defined by the US Copyright Act
Rights and permissions
About this article
Cite this article
Zhao, H., Dupont, J., Yakar, S. et al. PTEN inhibits cell proliferation and induces apoptosis by downregulating cell surface IGF-IR expression in prostate cancer cells. Oncogene 23, 786–794 (2004). https://doi.org/10.1038/sj.onc.1207162
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207162
Keywords
This article is cited by
-
Evaluation of the cardioprotective potential of extracellular vesicles – a systematic review and meta-analysis
Scientific Reports (2018)
-
The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer’s disease
Molecular Brain (2015)
-
INPP4B suppresses prostate cancer cell invasion
Cell Communication and Signaling (2014)
-
High expression of miR-21 in triple-negative breast cancers was correlated with a poor prognosis and promoted tumor cell in vitro proliferation
Medical Oncology (2014)
-
Phosphorylated insulin-like growth factor-1 receptor expression predicts poor prognosis of Chinese patients with gastric cancer
Medical Oncology (2014)